GlaxoSmithKline (GSK)

GlaxoSmithKline Sells Australian Drugs to Aspen for $270 Million

Biotech M&A at 4-Year High as Pharma Faces Expiring Patents

EU Crisis Piles on Pain for Europe's Drugmakers

Sick Europe Forces GSK to Cut 2012 Sales Outlook

The Long Way Back

Surge in Biotech Deals to Unlock Big Investor Profits

GlaxoSmithKline Set for Human Genome Takeover

EU Agency Lifts Lid on Drug Data Secrets

Celgene Mulls Human Genome Sciences Bid

GlaxoSmithKline Settles Healthcare Fraud Case for $3 Billion

GSK Again Extends its $2.6 Billion Human Genome Offer

US Top Court Rules for Glaxo on Overtime Pay

Human Genome Sets July 16 Deadline for Bids

GSK Eyes Replacing Human Genome Board

GSK Partner Pronova Wins Fish Oil Drug Patent Fight

GSK Goes Hostile with $2.6 bln Human Genome Offer

Amgen to Buy Turkish Drugmaker for $700 mln

Astra Fuels Biotech M&A with $1.3 bln Ardea Buy

US High Court Hears Glaxo Overtime Pay Case

Chasing Cheaper Cancer Drugs

GSK Confirms £500 Million UK Investment Plans

GSK, Others Vie to Buy Turkish Drugmaker

Stefan Borgas Fired as Lonza CEO

Pharma Asks The Money Question Earlier For New Drugs

Topics • Technology

Investments in Cincinnati on the Rise

Global Pharma to Pump Cash Into Russia

Blackstone, Prestige Jointly Bid For GlaxoSmithKline's OTC Portfolio

GlaxoSmithKline Swings to Profit In Q2

Hong Kong Orders GSK To Recall Antibiotic Due to Plasticizer

Whistleblower Rule Clears Divided U.S. SEC

India's Sun Pharma, US Merck in Generics Joint Venture

No Proof Of Drug Industry Sway On WHO In Pandemic

Topics • Strategy

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

Rx-360 Continues to Intensify Work in 2011

EU Presses Pharma Companies for More Info on Patent Deals

39 more articles

Top-Feature

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

MOC – Event Center Messe München

A successful concept on course for expansion — maintenance Munich 2025

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Oracle Germany

ISPE D/A/CH e.V.

Novartis International AG

Thermo Fisher Scientific

Sanofi S.A.

Microinnova Engineering GmbH

EvaluatePharma

Society of Chemical Industry (SCI)

GlaxoSmithKline (GSK) plc

Chemical Market Reporter

Thomson Reuters

Cincinnati USA Reg. Chamber

EDB Singapore

Novo Nordisk A/S